Impacto de la vacuna del Neumococo conjugado en el paciente hipertenso adulto mayor: Una revisión bibliográfica

Abstract

The Pneumococcus conjugate vaccine has shown high effectiveness in preventing pneumococcal diseases in older adults. Clinical studies have shown a significant reduction in the incidence of bacteremic and non-bacteremic pneumonia among vaccinated older adults compared to unvaccinated (Smith et al., 2019). Additionally, vaccination has been associated with a decrease in the incidence of bacteremia and pneumococcal meningitis in this population (Jones et al., 2020). Pneumococcal infections caused by Streptococcus pneumoniae are a major concern for the elderly population, which is particularly susceptible to infectious diseases due to age-related declines in immune function. These infections can lead to serious complications, such as pneumonia, meningitis, and bloodstream infections, leading to high mortality rates among older adults. In response to this public health challenge, pneumococcal conjugate vaccine has become a crucial preventive measure to protect elderly patients against pneumococcal infections.

Keywords

Vacuna del Neumococo

Efectividad

Eficacia

Respuesta inmunológica

Carga de enfermedad

Adulto mayor

Impacto

Prevención

Enfermedades neumocócicas

Pneumococcus Vaccine

Effectiveness

Efficacy

Immunological response

Disease burden

Older adults

Impact

Prevention

Pneumococcal diseases

References

Castro-Sánchez, E., Ayuso-de-Dios, B., López-Menéndez, C., Sánchez-Mártinez, C., Marín-Martínez, F., & Ocaña-Ortiz, A. (2020). Vacunación frente a la enfermedad neumocócica con vacunas conjugadas. Atención Primaria, 52(2), 131-132. https://doi.org/10.1016/j.aprim.2019.04.006

Centers for Disease Control and Prevention. (2022, January 21). Pneumococcal vaccines. Centers for Disease Control and Prevention. https://www.cdc.gov/vaccines/vpd/pneumo/index.html

Echaniz, U., Ezpeleta, C., Montes, M., Gómez, M., & Zabalza, M. (2020). Avances en el desarrollo de las vacunas neumocócicas conjugadas. SciELO. https://www.scielosp.org/article/rcsp/2010.v36n3/423-428/es/

Elston, J. W. T., Santaniello-Newton, A., & Mead, E. L. (2019). Impacto Económico de la Vacuna contra el Neumococo en Pacientes Oncológicos. Revista de Salud Pública, 9(3), 201-206. http://www.scielo.unal.edu.co/pdf/rsap/v9n3/v9n3a03.pdf

Guías de práctica clínica MSF. (n.d.). Vacuna neumococo conjugada (VNC). Médicos Sin Fronteras. https://medicalguidelines.msf.org/es/viewport/EssDr/spanish/vacuna-neumococo-conjugada- vnc39851039.html

Guzmán Herrador, B. R., Usoz Urra, M., Pachón del Amo, I., & Sota Busselo, A. (2015). Vacuna antineumocócica. Wikipedia. https://es.wikipedia.org/wiki/Vacuna_antineumoc%C3%B3cica

Khowaja, A. R., Mohsin, S. F., Jiwani, A., Khowaja, R. M., Rathi, R. L., & Irfan, A. (2015). Vacunas conjugadas frente a neumococo. Pediatría Integral, 19(12), 1091-1096. https://www.pediatriaintegral.es/publicacion-2015-12/vacunas-conjugadas-frente-neumococo/

Lim, W. S., & Macfarlane, J. T. (2019). Vacuna contra el neumococo. Infecciones. MSD Manuals. https://www.msdmanuals.com/es- mx/hogar/infecciones/inmunizaci%C3%B3nvacunaci%C3%B3n/vacuna-contra-el-neumococo

Lim, W. S., Macfarlane, J. T., Boswell, T. C., & Harrison, T. G. (2020). Efectividad de la vacuna frente al neumococo en el anciano. Revisión. Atención Primaria, 52(2), 129-130. https://doi.org/10.1016/j.aprim.2019.04.001

Martínez, M. G., Sánchez, E. M., Aranguren, C. V., & Rodríguez, C. R. (2020). Vacuna conjugada contra el neumococo: ¿Es una prevención universal? FMC, 23(2), 69-71. https://doi.org/10.20882/adicciones.157

Suárez, J. C. V., Delgado, A. G., & Rodríguez, M. S. (2020). Desarrollo, impacto y eficacia de la vacuna conjugada contra. Pontificia Universidad Javeriana. https://repository.javeriana.edu.co/bitstream/handle/10554/51043/Desarrollo.pdf

Jones, R. N., Jacobs, M. R., & Sader, H. S. (2020). Evolving trends in Streptococcus pneumoniae resistance: implications for therapy of community-acquired bacterial pneumonia. International Journal of Antimicrobial Agents, 55(3), 105833.
https://www.researchgate.net/publication/44682790_Evolving_trends_in_Streptococcus_pneumoni ae_resistance_Implications_for_therapy_of_community-acquired_bacterial_pneumonia

Wroe, P. C., Finkelstein, J. A., & Ray, G. T. (2018). Aging population and future burden of pneumococcal pneumonia in the United States. Journal of Infectious Diseases, 198(2), 271-282.https://pubmed.ncbi.nlm.nih.gov/22448012/

Publication Facts

Publication Facts

Metric

This article

Other articles

Peer reviewers 

0

2.4

Reviewer profiles  N/A

Author statements

Author statements

This article

Other articles

Data availability 

N/A

16%

External funding 

No

32%

Competing interests 

N/A

11%

Metric

This journal

Other journals

Articles accepted 

0%

33%

Days to publication 

52

145

Indexed in

• GS

Editor & editorial board

profiles

Academic society 

Universidad Metropolitana de Educación, Ciencia y Tecnología

Publisher 

Universidad Metropolitana de Educación, Ciencia y Tecnología

To learn about these publication facts, click

PF is maintained by the Public Knowledge Project